
The Drug Controller General of India (DCGI) has directed regulators to take steps to curb black marketing of remdesivir following a complaint black marketing and overpricing of antiviral drug by certain unscrupulous persons.
source https://www.pharmatutor.org/pharma-news/2020/dcgi-asks-regulators-to-curb-black-marketing-of-remdesivir
No comments:
Post a Comment